Comments on: Nasus Pharma announces publication of its pivotal study comparing its FMXIN001 powder nasal Naloxone to NarcanĀ® https://www.nasuspharma.com/nasus-pharma-announces-publication-of-its-pivotal-study-comparing-its-fmxin001-powder-nasal-naloxone-to-narcan-r/?utm_source=rss&utm_medium=rss&utm_campaign=nasus-pharma-announces-publication-of-its-pivotal-study-comparing-its-fmxin001-powder-nasal-naloxone-to-narcan-r New frontier in Intranasal drug delivery Tue, 07 Jun 2022 07:08:01 +0000 hourly 1 https://wordpress.org/?v=6.8